A B Yeom Supplementary Fig.2

Slides:

Advertisements

Similar presentations

Electronic Supplementary Material (ESM) Electronic Supplementary Figure 1. Plasma apoCI is associated with increased survival of patients with severe sepsis.

Advertisements

NORMAL CURVE Needed for inferential statistics. Find percentile ranks without knowing all the scores in the distribution. Determine probabilities.

Normal Distributions What is a Normal Distribution? Why are Many Variables Normally Distributed? Why are Many Variables Normally Distributed? How Are Normal.

57445 HCC were registered HCC with complete data underwent surgical resection 9577 underwent local ablation therapies 9283 underwent TACE 1150.

Figure 6: Risks of outcomes in the primary (A) and secondary (B) prevention cohorts for men in various BMI groups compared to patients in the “normal BMI”

Table 1. Characteristics of patients and the results of the log-rank test of prognostic factors Median (range) No. of patients No. of CRPC Median progression.

Clinical Trials 2015 Practical Session 2. Exercise I Normally Distributed Response Data H 0 :  = 0 H a :  =  a > 0 n=? α=0.05 (two-sided) β=0.20 

Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: BNP-Guided vs Symptom-Guided Heart Failure Therapy:

Table S1. Logistic regression analysis for the variables associated with the degree of change in cTnT between 2 time points (n=89) UnivariateMultivariate.

Supplementary Appendix Thrombotic Risk Scores % of Patients Risk Categories Low Risk (n=3491) Intermediate Risk (n=2806)

CPEB4 and IRF4 expression in peripheral mononuclear cells are potential prognostic factors for advanced lung cancer Yi-Ying Wu, Yi-Ting Hwang, Wann-Cherng.

Volume 6, Issue 8, Pages e1 (August 2009)

Yun Hyung Koog, Jin Su Lee, Hyungsun Wi

Table 1. Baseline Characteristics of the 36,636 Study Subjects

Lung squamous cell carcinoma

From: Coronary Artery Plaque Burden and Perioperative Cardiac Risk

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Fig. 1 Kaplan–Meier curves of post-progression survival (PPS) in the docetaxel and best supportive care (BSC) groups. Median PPS was 5.4 months in the.

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

Supplementary Figure 1 Representative images of neuroendocrine liver metastases in a non-contrast, low-attenuation CT scan (A), with lesion delineated.

CD25 expression is associated with unfavorable clinical outcome.

Bootstrap Confidence Intervals using Percentiles

WT G>A G>C G>T (n = 93) (n = 21) (n = 10) (n = 51)

Volume 117, Issue 5, Pages (November 1999)

Nicolas Girard, MD, Julie Teruya-Feldstein, MD, Eden C

Andrew Feber, PhD, Liqiang Xi, MD, PhD, Arjun Pennathur, MD, William E

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Minimally Invasive Versus Sternotomy Approach for Mitral Valve Surgery in Patients Greater Than 70 Years Old: A Propensity-Matched Comparison David M.

Prognostic Value of Undetectable hs Troponin T in Suspected Acute Coronary Syndrome Mehrshad Vafaie, MD, Anna Slagman, VD, MSc, Martin Möckel, MD, PhD,

Tutorial 9 Suppose that a random sample of size 10 is drawn from a normal distribution with mean 10 and variance 4. Find the following probabilities:

Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis M. Proesmans, F. Vermeulen,

Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism–related genes Ruben Pio, PharmD, PhD, Jackeline.

Patients who have received chemotherapy (n=60)

Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization Peter A. Soden, MD, Sara L. Zettervall, MD, MPH,

Shock Index and Decreased Level of Consciousness as Terminal Cancer Patients' Survival Time Predictors: A Retrospective Cohort Study Ko Sato, MD, Hideto.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Disease-specific survival

Volume 53, Issue 1, Pages (January 2008)

Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased Fiona D.M. van Schaik, Martijn G.H.

Should Patients with Extrapulmonary Small-Cell Carcinoma Receive Prophylactic Cranial Irradiation? Jarushka Naidoo, MB BcH BAO, MRCPI, Min Yuen Teo,

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

American Journal of Kidney Diseases

Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis Suvitesh.

Prognostic factors in clinical stage I non–small cell lung cancer

Mintu P. Turakhia et al. JACEP 2016;2:

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Higher CD34+ and CD3+ Cell Doses in the Graft Promote Long-Term Survival, and Have No Impact on the Incidence of Severe Acute or Chronic Graft-versus-Host.

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Perioperative administration of fibrinogen does not increase adverse cardiac and thromboembolic events after cardiac surgery J. Fassl, G. Lurati Buse,

Comparison of open and endovascular treatment of patients with critical limb ischemia in the Vascular Quality Initiative Jeffrey J. Siracuse, MD, Matthew.

Ruth H. Keogh, Sanja Stanojevic Journal of Cystic Fibrosis

Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.

Characteristics of Malignant Pleural Mesothelioma in Women

High CDK6 expression predicts poor prognosis in EOC patients

Volume 156, Issue 6, Pages e12 (May 2019)

Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed D.

Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes.

OS by OR for the Sorafenib plus HAIC Group

Fig. 3. Improved clinical responses to CD19 CAR-T cell immunotherapy after Cy/Flu lymphodepletion. Improved clinical responses to CD19 CAR-T cell immunotherapy.

Increase of physical activity over time associated with lower HF risk

Volume 60, Issue 2, Pages (August 2001)

Expression analysis of IGFBP-3 using human whole-genome microarray.

MiR-520d-3p is an independent positive prognostic factor in ovarian cancer. miR-520d-3p is an independent positive prognostic factor in ovarian cancer.

Fig. 1. Classification of the Kaplan-Meier curves and Cox survival estimates for the OS of patients using the pSPC in Cohort_C and in the overall population.

Kaplan–Meier curves for PFS and OS (for patients treated with anti-PD-1/PD-L1 monotherapy). Kaplan–Meier curves for PFS and OS (for patients treated with.

Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier plots. Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier.

Francisco Alcocer, MD, Marjan Mujib, MD, Bruce Lowman, MD, Mark A

The ROC curves analyzing the sensitivity and specificity of rCBVmax values in astrocytomas for 1-year survival (A) and recurrence (B) show the optimal.

A and B, The ROC curves analyzing the sensitivity and specificity of the WHO grading system (I-IV) for the 1-year survival (A) and recurrence (B) show.

A. B. C. D. Above median: Below median:

Presentation transcript:

A B Yeom Supplementary Fig.2 Expression Median Survival P value* HR (95% CI)** Above P75 (n=85) 408 0.0027 1.48 (1.17-2.09) Below P75 (n=258) 603 0.68 (0.48-0.86) Above P50 (n=171) 570 0.5569 1.09 (0.87-1.37) Below P50 (n-172) 600 0.92 (0.73-1.15) Above P25 (n=258) 540 0.0684 0.78 (0.61-1.02) Below P25 (n=85) 561 1.28 (0.98-1.64) Supplementary Figure 2. RRAD expression levels and their association with survival (A) and probability of unfavorable events (B) in glioma patients. P75, 75% percentile; . P50, 50% percentile; . P25, 25% percentile; *log-rank test; **HR, Hazard raio; 95% CI, 95% confidence interval (univariate analysis)